Effect of fixed-ratio insulin combinations on adherence in type 2 diabetes: Systematic review

被引:1
作者
Elamin, Mohamed [1 ]
Barnish, Maxwell S. [2 ]
机构
[1] Univ Exeter, Med Sch, Exeter, England
[2] Univ Exeter, Med Sch, Dept Publ Hlth & Sports Sci, Exeter, England
关键词
Type; 2; diabetes; Fixed -ratio combinations; Adherence; Narrative synthesis; BASAL INSULIN; REAL-WORLD; IDEGLIRA; BARRIERS; THERAPY; PEOPLE; SAFETY;
D O I
10.1016/j.dsx.2024.103072
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aims: To systematically review evidence on the effect of fixed-ratio combinations on adherence in people with type 2 diabetes. Methods: Systematic searches were conducted using MEDLINE and EMBASE in March 2023. Standardised screening, data extraction and risk of bias assessment were conducted. All review procedures were conducted independently by two reviewers. Eligible studies assessed the effect of fixed-ratio combinations on adherence in people with type 2 diabetes. Narrative synthesis was conducted to analyse findings. Results: A total of 488 records were identified, of which 37 proceeded to full-text screening and 7 - each representing a unique study - were included in the systematic review. Among the included studies, 3 were randomised controlled trials and 4 were cohort studies. Following narrative synthesis, it was shown that fixed-ratio combinations improved patient satisfaction and treatment adherence. Conclusions: Available evidence supports a benefit for fixed-ratio combinations on patient satisfaction and treatment adherence in people with type 2 diabetes.
引用
收藏
页数:7
相关论文
共 37 条
[21]   iGlarLixi versus premixed insulin initiation in adults with type 2 diabetes advancing from basal insulin therapy: The SoliComplex real-world study [J].
Lajara, Rosemarie ;
Heller, Caroline ;
Pantalone, Kevin M. ;
Lew, Elisheva ;
Li, Xuan ;
Dex, Terry ;
Kilpatrick, Catherine Rachel .
DIABETES OBESITY & METABOLISM, 2023, 25 (05) :1249-1260
[22]  
Leiter Lawrence., 2005, Assessment of the impact of fear of hypoglycemic episodes on glycemic and hypoglycemic management
[23]  
Magliano D., 2021, IDF Diabetes Atlas, V10th ed
[24]   Treatment Deintensification Is Uncommon in Adults With Type 2 Diabetes Mellitus A Retrospective Cohort Study [J].
McAlister, Finlay A. ;
Youngson, Erik ;
Eurich, Dean T. .
CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES, 2017, 10 (04)
[25]   Advancing therapy with iGlarLixi versus premix BIAsp 30 in basal insulin-treated type 2 diabetes: Design and baseline characteristics of the SoliMix randomized controlled trial [J].
McCrimmon, Rory J. ;
Al Sifri, Saud ;
Emral, Rifat ;
Mohan, Viswanathan ;
Sauque-Reyna, Leobardo ;
Trescoli, Carlos ;
Lalic, Nebojsa ;
Alvarez, Agustina ;
Demil, Nacima ;
Coudert, Mathieu ;
Shaunik, Alka ;
Bonnemaire, Mireille ;
Rosenstock, Julio .
DIABETES OBESITY & METABOLISM, 2021, 23 (06) :1221-1231
[26]   Metabolic Control and Adherence to Therapy in Type 2 Diabetes Mellitus Patients Using IDegLira in a Real-World Setting [J].
Melzer-Cohen, Cheli ;
Chodick, Gabriel ;
Naftelberg, Shiran ;
Shehadeh, Naim ;
Karasik, Avraham .
DIABETES THERAPY, 2020, 11 (01) :185-196
[27]  
Miller E, 2018, Endocr Pract, V24, P48
[28]   IDegLira improves patient-reported outcomes while using a simple regimen with fewer injections and dose adjustments compared with basal-bolus therapy [J].
Miller, Eden ;
Doshi, Ankur ;
Gron, Randi ;
Jodar, Esteban ;
Orsy, Petra ;
Ranthe, Mattis F. ;
Sugimoto, Danny ;
Tentolouris, Nikolaos ;
Viljoen, Adie ;
Billings, Liana K. .
DIABETES OBESITY & METABOLISM, 2019, 21 (12) :2643-2650
[29]   Barriers and facilitators to self-monitoring of blood glucose in people with type 2 diabetes using insulin: a qualitative study [J].
Ong, Woon May ;
Chua, Siew Siang ;
Ng, Chirk Jenn .
PATIENT PREFERENCE AND ADHERENCE, 2014, 8 :237-246
[30]   Real-world study on the effectiveness and safety of basal insulin IDegLira in type 2 diabetic patients previously treated with multi-injective insulin therapy [J].
Persano, M. ;
Nollino, L. ;
Sambataro, M. ;
Rigato, M. ;
Negro, I ;
Marchetto, S. ;
Paccagnella, A. .
EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2021, 25 (02) :923-931